| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099214 For prophylaxis and therapy of pruritus |
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099209 Dihydrostilbene alkanoic acid derivatives |
| 07/25/2002 | US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 07/25/2002 | US20020099207 Has activity as an antagonist to neurokinin 1 receptors; for therapy of benign prostatic hyperplasia (BPH) |
| 07/25/2002 | US20020099202 Compoound for use in the sequencing of nucleic acids |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099102 Process for producing carotenoid emulsion |
| 07/25/2002 | US20020099100 Treatment of dry eye syndrome |
| 07/25/2002 | US20020099098 Method for treating sexual disorders |
| 07/25/2002 | US20020099097 Pharmaceutical solutions of modafinil compounds |
| 07/25/2002 | US20020099096 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer |
| 07/25/2002 | US20020099095 For treatment and prophylactic treatment of ageing of the skin, for pretreatment or after-treatment of hair or scalp or of the hair root region, in particular before or after hair treatment, for example during colouring |
| 07/25/2002 | US20020099094 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris |
| 07/25/2002 | US20020099092 For therapy of neurological conditions, e.g. epilepsy and pain |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099087 Vanadium (iv) metallocene complexes having spermicidal activity |
| 07/25/2002 | US20020099086 Treating cachexia from AIDS or cancer; use of eupomatenoid-7, Licarin-A, an aristolactam, and a 2-hydroxy-1-tetralone compound; using Aristolochia taliscana extracts |
| 07/25/2002 | US20020099085 Treating a cell with a bilin such as bilirubin or biliberdine; bone or cartilage formation and repair, regulation of spermatogenesis, smooth muscle, hematopoietic function, skin and hair growth |
| 07/25/2002 | US20020099082 Such as troglitazone, ciglitazone, pioglitazone, or englitazone |
| 07/25/2002 | US20020099079 Treating psoriasis, ulcers, gastroesophageal reflux and conditions caused by gastric hypersecretion including Zollinger-Ellison Syndrome, by administering hydroxylansoprazole or salt |
| 07/25/2002 | US20020099076 Dementias include alzheimer's disease, Lewy Body Dementia, Vascular Dementia, Dementia in Parkinson's Disease, Fronto-Temporal Dementia, Pick's Disease and Corticobasal Degeneration |
| 07/25/2002 | US20020099075 Combination therapy |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis |
| 07/25/2002 | US20020099066 Antitumour 1,5-diazaanthraquinones |
| 07/25/2002 | US20020099065 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/25/2002 | US20020099064 Analgesic combination of oxycodone and T-614 |
| 07/25/2002 | US20020099061 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine adenosine A2a receptor antagonists; use in the treatment of central nervous system diseases, in particular Parkinson's disease |
| 07/25/2002 | US20020099060 Combination of pseudoephedrine, acetaminophen, and caffeine in an amount effective to reduce the migraine pain and functional disability characterics of a migraine attack. |
| 07/25/2002 | US20020099059 A selective 5-hydroxytriptamine receptor agonist and acetaminophen, non-steroidal anti-inflammatory agents and/or caffeine. |
| 07/25/2002 | US20020099058 Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| 07/25/2002 | US20020099057 Treatment of accidental extravasation of anthracyclines |
| 07/25/2002 | US20020099055 Novel compounds |
| 07/25/2002 | US20020099054 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 07/25/2002 | US20020099051 Anticancer treatment using triptolide prodrugs |
| 07/25/2002 | US20020099049 Analgesic combination of oxycodone and meloxicam |
| 07/25/2002 | US20020099048 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 07/25/2002 | US20020099046 Atorvastatin or a pharmaceutically acceptable salt thereof and an antihypertensive agent such as a calcium channel blocker, an ACE inhibitor, an A-II antagonist, a diuretic, a beta- or alpha adrenergic receptor blocker |
| 07/25/2002 | US20020099045 Administering a sigma receptor ligand in combination with an antidepressant agent; especially for refractory depression |
| 07/25/2002 | US20020099044 Composition comprising amoxycillin and clavulanic acid |
| 07/25/2002 | US20020099043 Freeze-dried product and method for preparing the same |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | US20020099037 Glycerophosphates, particularly calcium glycerophosphate, used to treat irritable bowel syndrome, interstitial cystitis, inflammatory bowel disease, fibromyalgia, urinary urgency, benign prostatic hypertrophy, and vulvodynia |
| 07/25/2002 | US20020099036 Selective androgen receptor modulators and methods of use thereof |
| 07/25/2002 | US20020099033 Method and composition for treating sleep apnea |
| 07/25/2002 | US20020099032 Preparations and method of producing the same |
| 07/25/2002 | US20020099031 Hemostatic agent |
| 07/25/2002 | US20020099030 Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties |
| 07/25/2002 | US20020099029 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099023 Treating chronic obstructive pulmonary disease by administering an osmotically active compound to an airway surface of the subject in an amount effective to increase the volume of liquid on the airway surface. |
| 07/25/2002 | US20020099022 Anti-viral composition |
| 07/25/2002 | US20020099021 Carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, and unproductive cough |
| 07/25/2002 | US20020099020 Oil blend of omega-3- and omega-6- fatty acids; branched amino acid; antioxidant comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof; in a liquid nutritional matrix. |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020099004 Inhibiting or abolishing the protein cleaving action of plasmin, and inhibiting or abolishing the protein cleaving action of a murine metalloprotease. |
| 07/25/2002 | US20020099003 Also improving vaginal muscle tone and tissue health, preventing vaginal atrophy, preventing vaginal pain during sexual intercourse, and alleviating vaginal itching and dryness; applying to the vagina and/or vulvar region |
| 07/25/2002 | US20020098998 P27 prevents cellular migration |
| 07/25/2002 | US20020098980 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
| 07/25/2002 | US20020098979 Method of controlling zoological and aquatic plant growth |
| 07/25/2002 | US20020098978 Method of controlling zoological and aquatic plant growth |
| 07/25/2002 | US20020098582 Differentiated stem cells suitable for human therapy |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098469 Extracorporeal methods for enhancing antigen presentation and immune responsiveness |
| 07/25/2002 | US20020098278 Coated implantable medical device |
| 07/25/2002 | US20020098274 Conjugated linoleic acid compositions |
| 07/25/2002 | US20020098264 Rapid release of nicotine over the first few minutes of chewing added in absroption into the bloodstream by a buffer followed by slower release over a period of 30 minutes or more |
| 07/25/2002 | US20020098252 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/25/2002 | US20020098247 May also include cyclooxygenase inhibitor, mucolytic agent (guaifenesin), and salicin-containing herb which facilitates gastrointestinal tract absorption of chromium |
| 07/25/2002 | US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 07/25/2002 | US20020098240 Compositions comprising modafinil compounds |
| 07/25/2002 | US20020098237 Neurotoxin implant |
| 07/25/2002 | US20020098233 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 07/25/2002 | US20020098231 Antisense nucleotides; drug delivery; anticancer agents; gene expression inhibition |
| 07/25/2002 | US20020098224 Comprising histamine, its receptor analog, serotonin and its receptor analog in an opthalmic solution or gel for reducing irritation due to infection, allergies, pollutants and other irritants in a pharmaceutically acceptable carrier |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098219 For treating xeric stress, comprising mixtures of ceramides and essential and nonessential free fatty acids, and mixtures of a beta - glucoerebrosidase and a phopholipase A2 |
| 07/25/2002 | US20020098218 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |
| 07/25/2002 | US20020098208 Immersion of the aquatic animal (aquarium fish) in the antimicrobial solution containing EDTA and buffering agent; kits |
| 07/25/2002 | US20020098207 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 07/25/2002 | US20020098205 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098199 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences |
| 07/25/2002 | US20020098198 Comprising therapeutic agent and solid foam formed from a protein and which is prepared by heating; dissolves rapidly in mouth, useful for children |
| 07/25/2002 | US20020098186 Use of endothelin inhibitors for treatment or prevention of fibrotic disorders |
| 07/25/2002 | US20020098185 Administering therapeutically effective amount of IL-18 antagonist; treatment of rheumatoid arthritis, inflammatory bowel disease |
| 07/25/2002 | US20020098180 For bacterial and viral diseases such as those caused by Gram positive and Gram negative bacteria, Dengue 2 virus and viral encephalitis |
| 07/25/2002 | US20020098173 Amyloid modulators of an A beta aggregation core domain and a modifying group coupled to it |
| 07/25/2002 | US20020098172 Improved absorption of Coenzyme Q10 into an intestinal tract and to maintain basal blood levels; 30-100 mg/day of coenzyme Q10, polyglycerol oleate and vitamin e |
| 07/25/2002 | US20020098169 Novel sequences and their use |
| 07/25/2002 | US20020098166 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 07/25/2002 | US20020098164 Treatment of tumor metastases and cancer |
| 07/25/2002 | US20020098162 Decoy which antagonizes the nucleic acid domain to which NF-kappa B is bound; antiischemic, inflammatorie, anticancer agents and treatment of cachexia and autoimmune diseases |
| 07/25/2002 | US20020098161 Therapeutic polyanhydride compounds for drug delivery |
| 07/25/2002 | US20020098159 Surfactants and organic and/or inorganic acids |
| 07/25/2002 | US20020098112 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus |